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I have read, with great enthusiasm, the article 
entitled “Botulinum toxin type-A as an alternative 
treatment for gummy smile: a case report”, authored 
by Juliane Pirágine Araújo and colleagues [1], 
published in the July 2018 edition of Dermatology 
Online Journal. The article is very interesting and 
discusses the application of botulinum toxin in a 
patient with severe gummy smile. The application of 
botulinum toxin in cases of gummy smile is an 
excellent treatment option at present. However, the 
therapeutic association of gingivoplasty and 
application of botulinum toxin type A, when 
indicated, should be performed. I have performed 
the combination of these techniques at the 
Universidade Brasil and Bottoxindent Institute (São 
Paulo, Brazil) for some years now.  
As reported by Araújo and colleagues [1] in the 
mentioned article, the institution of treatment 
depends on the etiology of the gummy smile, which 
is multifactorial and may be gingival, dental, skeletal, 
muscular, or a combination of these. Unfortunately, 
there are many reports presenting botulinum toxin 
as the only form of treatment for gummy smile, with 
little mention of the gingival surgical mediation that 
would promote gingival health. The case was very 
well discussed and I congratulate the authors Araújo 
and colleagues for the article presented. However, I 
consider it is important to highlight some points and 
make some suggestions: 
The technique of botulinum toxin application has 
been presented as a minimally invasive technique, 
which can only be considered as compared to more 
invasive techniques, such as myotomy or Le Fort I 
osteotomy (orthognathic surgery). Some may 
consider this an invasive technique in which 
intradermal needles are employed [2]. 
 
I suggest the photographic presentation of the 
entire face of the patient, since the facial shape and 
the biotype of the patient can provide important 
information for planning and execution of the 
surgical technique to be used. I have observed that 
patients with gummy smile present a dolichofacial 
profile in the cephalometric analysis most of the 
time. This observation favors not only the initial 
evaluation, but also the evaluation of the patient's 
dentogingivofacial harmonization after the 
institution of the treatments, seeking aesthetic and 
functional balance. Thus, the vertical maxillary 
excess as an etiological factor can only be considered 
if the facial length is evaluated. Therefore, evaluation 
Abstract 
Currently, the search for esthetic excellence has 
become the main objective in the facial treatment. 
The gummy smile is one of the complaints from the 
patients, since this situation may influence their self-
esteem and social relationship. The development of 
new techniques, such as the application of 
botulinum toxin, may be a conservative therapeutic 
option in the treatment of gummy smile. The 
purpose of this letter is to comment some points 
about a case report publicated in Dermatology 
Online Journal, of a patient with dentogingival 
discrepancy and severe gummy smile, who was 
treated with application of botulinum toxin in order 
to optimize the harmony of the smile. 
Volume 25 Number 6| June 2019| 
25(6):16 
 
 
- 2 - 
Dermatology Online Journal  ||  Letter 
of the face and/or head of the patient is important [2-
4]. 
If the function of the levator labii superioris muscle 
was considered as the cause, why was the botulinum 
toxin applied bilaterally in the zygomatic muscle 
region (see Figure 2, reference [1]). Sometimes the 
zygomaticus minor muscle presents as fibers of the 
zygomaticus major muscle, or is even classified by 
anatomists as bundles of the zygomaticus major 
muscle. The functional evaluation of muscles in these 
cases, could only be determined by the use of 
electromyography, which was not reported in the 
article by Araújo and colleagues [1].  
There were two very close application points 
between the two muscle groups. It is known that 
the diffusion halo of botulinum toxin within the 
muscle is 20mm on average. Therefore, by 
evaluating the cited Figure 2, [1], the two bilateral 
points next to each nostril are not well 
demonstrated and also cover the same muscles of 
a single point of application, as we have 
recommended [2-4]. The Yonsei point is 
advocated, located next to each nostril, proposed 
by Hwang et al. [5] and named in honor of its 
university of origin — Yonsei University College of 
Dentistry (Seoul, South Korea). This point comprises 
the intersection among levator labii superioris, 
levator labii superioris alaeque nasii, zygomaticus 
minor, and major muscles, the first three being the 
main muscles involved and responsible for lip 
elevation.  
Similar cases were presented by our group, applying 
2 units of botulinum toxin type A (Botox®, Allergan 
Pharmaceuticals, Westport, Ireland) next to each 
nostril (Yonsei point), achieving satisfactory results 
for the patient who presented severe gummy smile 
[3, 4]. Even if needed retouching or (re- application), 
injection into the Yonsei point would yield a 
satisfactory result [2]. 
Even following the manufacturer's guidance, I 
believe it is more interesting to dilute 1ml per 100 
units in order to reach the predicted maximum 
duration of botulinum toxin, which varies from 3 to 6 
months depending on the trademark available in the 
Brazilian market. Regarding the administration, it is 
worth emphasizing the importance of the use of 
dermatological topical anesthetic (Emla®, Astra, São 
Paulo, Brasil) to promote comfort during the 
injection of botulinum toxin [2]. 
Routinely, many colleagues report reversibility of 
botulinum toxin. However, there are no established 
and validated guidelines in the literature, only 
conjectures [2]. 
Additionally, it is worth noting that botulinum toxin 
has been widely used in several stomatological 
indications. In addition to the gingival smile, we can 
mention the parafunctional habits such as bruxism 
and briquism, masseteric hypertrophy, trismus, 
temporomandibular disorders, orofacial pain, facial 
paralysis, and sialorrhoea. It has also been useful in 
the prevention of excessive masticatory forces in the 
osseointegration phase in the treatment with 
osseointegrated implants and as an adjunct to 
buccomaxillofacial surgical procedures [2]. 
In our research group, we are developing a set of 
useful guidelines for the proper management of the 
gummy smile. 
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